Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 424B3 Offering Prospectus
  3. 425 Deal Prospectus/Communication re Business Combination
  4. S-4/A Deal Registration Statement - Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. S-4 Deal Registration Statement - Business Combination
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 10QSB Other 10QSB
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 8-K Event Item 5 · Item 7
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 10QSB Other 10QSB
  14. 10KSB/A Other 10KSB/A
  15. 10KSB/A Other 10KSB/A
  16. 10KSB Other 10KSB
  17. 424B3 Offering Prospectus
  18. S-3/A Offering Registration Statement
  19. 10KSB/A Other 10KSB/A
  20. 10QSB Other 10QSB

Page 67 of 72 · 1,429 filings